Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data

被引:223
作者
Bianchi, DW
Simpson, JL
Jackson, LG
Elias, S
Holzgreve, W
Evans, MI
Dukes, KA
Sullivan, LM
Klinger, KW
Bischoff, FZ
Hahn, S
Johnson, KL
Lewis, D
Wapner, RJ
机构
[1] Tufts Univ, Sch Med, Dept Pediat, Div Genet, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Dept Obstet & Gynecol, Div Genet, Boston, MA 02111 USA
[3] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA
[5] Jefferson Med Coll, Dept Med, Div Med Genet, Philadelphia, PA USA
[6] Jefferson Med Coll, Dept Obstet & Gynecol, Div Med Genet, Philadelphia, PA USA
[7] Med Coll Penn & Hahnemann Univ, Philadelphia, PA USA
[8] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL USA
[9] Univ Basel, Dept Obstet & Gynecol, Basel, Switzerland
[10] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI USA
[11] DM STAT, Medford, MA USA
[12] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA
[13] Genzyme Genet, Framingham, MA USA
[14] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA
[15] NICHHD, Mental Retardat Res Branch, Bethesda, MD 20892 USA
关键词
fetal cells in maternal blood; FISH; prenatal diagnosis; non-invasive;
D O I
10.1002/pd.347
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objectives The National Institute of Child Health and Human Development Fetal Cell Isolation Study (NIFTY) is a prospective, multicenter clinical project to develop non-invasive methods of prenatal diagnosis. The initial objective was to assess the utility of fetal cells in the peripheral blood of pregnant women to diagnose or screen for fetal chromosome abnormalities. Methods Results of fluorescence in situ hybridization (FISH) analysis on interphase nuclei of fetal cells recovered from maternal blood were compared to metaphase karyotypes of fetal cells obtained by amniocentesis or chorionic villus sampling (CVS). After the first 5 years of the study we performed a planned analysis of the data. We report here the data from 2744 fully processed pre-procedural blood samples; 1292 samples were from women carrying singleton male fetuses. Results Target cell recovery and fetal cell detection were better using magnetic-based separation systems (MACS) than with flow-sorting (FACS). Blinded FISH assessment of samples from women carrying singleton male fetuses found at least one cell with an X and Y signal in 41.4% of cases (95% Cl: 37.4%, 45.5%). The false-positive rate of gender detection was 11.1% (95% Cl: 6.1,16.1%). This was higher than expected due to the use of indirectly labeled FISH probes in one center. The detection rate of finding at least one aneuploid cell in cases of fetal aneuploidy was 74.4% (95% Cl: 76.0%, 99.0%,), with a false-positive rate estimated to be between 0.6% and 4.1%. Conclusions The sensitivity of aneuploidy detection using fetal cell analysis from maternal blood is comparable to single marker prenatal serum screening, but technological advances are needed before fetal cell analysis has clinical application as part of a multiple marker method for non-invasive prenatal screening. The limitations of the present study, i.e. multiple processing protocols, are being addressed in the ongoing study. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:609 / 615
页数:7
相关论文
共 19 条
  • [1] Bianchi DW, 1999, PRENATAL DIAG, V19, P994, DOI 10.1002/(SICI)1097-0223(199910)19:10<994::AID-PD662>3.0.CO
  • [2] 2-H
  • [3] Fetal cells in the maternal circulation: Feasibility for prenatal diagnosis
    Bianchi, DW
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 (03) : 574 - 583
  • [4] BIANCHI DW, 1992, HUM GENET, V90, P368
  • [5] DETECTION OF 47,XYY TROPHOBLAST FETAL CELLS IN MATERNAL BLOOD BY FLUORESCENCE INSITU HYBRIDIZATION AFTER USING IMMUNOMAGNETIC LYMPHOCYTE DEPLETION AND FLOW-CYTOMETRY SORTING
    CACHEUX, V
    MILESIFLUET, C
    TACHDJIAN, G
    DRUART, L
    BRUCH, JF
    HSI, BL
    UZAN, S
    NESSMANN, C
    [J]. FETAL DIAGNOSIS AND THERAPY, 1992, 7 (3-4) : 190 - 194
  • [6] PRENATAL-DIAGNOSIS BY USE OF FETAL CELLS ISOLATED FROM MATERNAL BLOOD
    DELACRUZ, F
    SHIFRIN, H
    ELIAS, S
    SIMPSON, JL
    JACKSON, L
    KLINGER, K
    BIANCHI, DW
    KAPLAN, SH
    EVANS, MI
    HOLZGREVE, W
    GANSHIRT, D
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 173 (04) : 1354 - 1355
  • [7] 1ST TRIMESTER PRENATAL-DIAGNOSIS OF TRISOMY-21 IN FETAL CELLS FROM MATERNAL BLOOD
    ELIAS, S
    PRICE, J
    DOCKTER, M
    WACHTEL, S
    THARAPEL, A
    SIMPSON, JL
    KLINGER, KW
    [J]. LANCET, 1992, 340 (8826) : 1033 - 1033
  • [8] GANSHIRTAHLERT D, 1993, AM J REPROD IMMUNOL, V30, P194
  • [9] Fetal cells in maternal blood: current and future perspectives
    Hahn, S
    Sant, R
    Holzgreve, W
    [J]. MOLECULAR HUMAN REPRODUCTION, 1998, 4 (06) : 515 - 521
  • [10] Oosterwijk JC, 1998, PRENATAL DIAG, V18, P1082, DOI 10.1002/(SICI)1097-0223(1998100)18:10<1082::AID-PD383>3.0.CO